Given common questions of fact and law raised in complaints brought throughout the federal court system, all GLP-1 lawsuits have...

The search for biomarkers for therapeutic response using traditional genomic sequencing and other omic approaches has not yielded clinically actionable...

Studies show 50% of patients don’t take their medication as prescribed. The top reasons for medication non-adherence include fear, cost...

In November, a group of plaintiffs filed a motion for transfer with the U.S. JPML, asking that cases brought throughout...

The Oncology Market: 2024 Year in Review This paper reviews key developments in the oncology market during 2024 and outlines...

In 2024, the pharma industry found itself with a growing “trust paradox.” While innovations like gene therapies and rare disease...

To help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated...

Cell and gene therapies (CGTs) offer fresh hope to patients with serious and debilitating diseases, often where no other treatment...

William is passionate about personalizing the patient experience so individuals can be more engaged in their healthcare and medications. As...